Extended Data Fig. 2: Best percent change from baseline in sum of diameters by local investigator review (N = 36). | Nature Medicine

Extended Data Fig. 2: Best percent change from baseline in sum of diameters by local investigator review (N = 36).

From: Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i

Extended Data Fig. 2

A total of 33 patients experienced a reduction in the size of the target lesion. One patient with SD had a best percent change of 0% in the target lesion. Best percent change in the target lesion was not available for 1 patient with PD. Best percent change in target lesion could not be calculated for 1 additional patient as best overall response was unknown. CR, complete response; PD, progressive disease; PR, partial response; SD, stable disease.

Back to article page